Skip to main navigation Skip to search Skip to main content

Indications related to antidepressant prescribing in the Nivel-PCD database and the SIDIAP database

  • University Hospital Vall d'Hebron
  • University Medical Center Groningen
  • Autonomous University of Barcelona

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

BACKGROUND: Antidepressant drug consumption has increased, mainly in the elderly. This trend could be explained by the use for indications other than depression. We aimed to describe the indications related to antidepressant drug new users in two primary care settings.

METHODS: A longitudinal study of new antidepressant users aged ≥65 was conducted, with data from the Nivel-PCD (The Netherlands) and SIDIAP (Catalonia) databases (2010-2015). As a proxy for indication, diagnoses registered around the 3 months of antidepressant prescribing were collected. Indications were classified in seven categories and an additional one of non-selected indications. The percentage and incidence calculated over the total population registered was described.

RESULTS: A total of 16,537 and 199,168 new antidepressant users were identified in the Nivel-PCD and SIDIAP databases, respectively (women aged 65-69 were the most prevalent). Depression was the most frequent indication (24.0% and 31.3%), followed by anxiety (12.5% and 19.5%) and sleep disorders (10.2% and 26.4%). Tricyclic antidepressants were the most commonly prescribed in Nivel-PCD (48.7%), mainly associated with neuropathic pain, and selective serotonin reuptake inhibitor antidepressants in SIDIAP (63.1%), associated with depression. The non-selected indications category showed an upward trend in the Nivel-PCD database while in the SIDIAP database it decreased.

LIMITATIONS: It is not mandatory for physicians to register a diagnosis with each prescription.

CONCLUSIONS: Depression was the most common prescribing indication in The Netherlands and Spain, followed by anxiety and sleep disorders. The most commonly prescribed antidepressant differed between the countries and is likely explained by differences in local guidelines.

Original languageEnglish
Pages (from-to)131-137
Number of pages7
JournalJournal of Affective Disorders
Volume303
Early online date5 Feb 2022
DOIs
Publication statusPublished - 15 Apr 2022

Bibliographical note

Publisher Copyright:
© 2022

Funding

This work was funded by The Instituto de Salud Carlos III, grant PI15/01429 cofinanced by the European Regional Development Fund (ERDF) and Utrecht University.

FundersFunder number
Universiteit Utrecht
Instituto de Salud Carlos IIIPI15/01429
European Regional Development Fund

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Antidepressant drug
    • Drug utilization
    • Electronic healthcare databases
    • Indications
    • Prescription

    Fingerprint

    Dive into the research topics of 'Indications related to antidepressant prescribing in the Nivel-PCD database and the SIDIAP database'. Together they form a unique fingerprint.

    Cite this